Aemetis, Inc (NASDAQ:AMTX) Short Interest Update

Aemetis, Inc (NASDAQ:AMTXGet Free Report) was the recipient of a large decrease in short interest during the month of March. As of March 13th, there was short interest totaling 4,691,245 shares, a decrease of 15.3% from the February 26th total of 5,537,109 shares. Based on an average daily volume of 1,305,036 shares, the days-to-cover ratio is currently 3.6 days. Currently, 8.4% of the shares of the company are short sold.

Aemetis Price Performance

Aemetis stock opened at $2.98 on Thursday. Aemetis has a 12 month low of $1.22 and a 12 month high of $3.66. The business has a 50 day simple moving average of $1.90 and a 200-day simple moving average of $1.95. The stock has a market capitalization of $198.56 million, a PE ratio of -2.24 and a beta of 2.61.

Aemetis (NASDAQ:AMTXGet Free Report) last posted its quarterly earnings data on Thursday, March 12th. The specialty chemicals company reported ($0.24) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.28) by $0.04. The firm had revenue of $43.31 million during the quarter, compared to analysts’ expectations of $72.07 million. As a group, equities research analysts anticipate that Aemetis will post -2.07 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Creative Planning acquired a new stake in Aemetis in the second quarter valued at about $30,000. Bank of America Corp DE boosted its holdings in Aemetis by 62.6% in the 3rd quarter. Bank of America Corp DE now owns 38,526 shares of the specialty chemicals company’s stock valued at $87,000 after purchasing an additional 14,836 shares in the last quarter. Tower Research Capital LLC TRC increased its position in Aemetis by 206.7% during the 2nd quarter. Tower Research Capital LLC TRC now owns 22,962 shares of the specialty chemicals company’s stock worth $57,000 after purchasing an additional 15,474 shares during the period. Engineers Gate Manager LP purchased a new position in shares of Aemetis during the 2nd quarter worth approximately $42,000. Finally, Centiva Capital LP purchased a new position in shares of Aemetis during the 3rd quarter worth approximately $39,000. 27.02% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on AMTX shares. Loop Capital set a $1.75 price objective on shares of Aemetis in a research report on Thursday, March 12th. Wall Street Zen raised shares of Aemetis from a “sell” rating to a “hold” rating in a report on Sunday, March 22nd. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Aemetis in a research note on Wednesday, January 21st. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $8.25.

View Our Latest Analysis on AMTX

About Aemetis

(Get Free Report)

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.

Featured Stories

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.